Lipid-lowering Efficacy Sustained Over 4 Years with Twice-yearly Injections of a First-in-class Therapy

Large Heart Failure Studies Challenge Definition of Reduced Heart Failure

Large PIONEER-HF Trial Validates Safety and Benefits of In-Hospital Initiation of Therapeutic Treatment

DECLARE-TIMI 58: Latest SGLT2 Cardiovascular Trial Supports Benefits beyond Glucose Control

Latebreaker Trial Shows Heart Failure Recovery Is Remission and Not a Cure

Upward PCSK9 Inhibitor Dose Titration Uncommonly Required to Reach Goal in Challenging Patients

PCSK9 Inhibitors Show Similar Efficacy in Diabetics as in Other High-Risk Groups

SPRINT Trial: Mortality Benefit Associated with Intensive Blood Pressure Control

Newer P2Y12 Inhibitors in ACS: Significant Reduction in Stent Thrombosis and Mortality

Progress in Development of Reversal Agent for New Oral Anticoagulants

Promising Treatment for Statin-Intolerant Patients with Very High Baseline LDL-C Levels

More Cardioprotection when a Non-statin Cholesterol-lowering Agent is added to a Statin